Company Filing History:
Years Active: 1987-2006
Title: Innovations of Tatsuo Yamashita
Introduction
Tatsuo Yamashita is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of hematopoietic stem cell research. With a total of 3 patents, his work has implications for medical treatments and therapies.
Latest Patents
One of his latest patents focuses on hematopoietic stem cell proliferating agents. This invention relates to a hematopoietic stem cell proliferating agent comprising IGF-I, along with at least one protein selected from SCF, M-CSF, and G-CSF. The method involves culturing hematopoietic stem cells in a medium containing IGF-I and these proteins. This agent promotes the proliferation of hematopoietic stem cells in an undifferentiated state, both in vivo and in vitro. It can be utilized for ameliorating cytopenia induced by radiotherapy or chemotherapy, preventing infectious diseases associated with lymphopenia, and for in vitro culture aimed at multiplying hematopoietic stem cells.
Career Highlights
Throughout his career, Tatsuo Yamashita has worked with prominent companies in the pharmaceutical industry, including Fujisawa Pharmaceutical Company, Ltd. and Astellas Pharma GmbH. His experience in these organizations has contributed to his expertise in the field of stem cell research.
Collaborations
He has collaborated with notable colleagues such as Yoshimasa Saito and Yoshiko Ueda. These partnerships have likely enhanced his research and development efforts in hematopoietic stem cell technologies.
Conclusion
Tatsuo Yamashita's innovative work in hematopoietic stem cell proliferating agents showcases his significant contributions to medical science. His patents and collaborations reflect a commitment to advancing healthcare solutions.